A fairy chemical, 2-aza-8-oxohypoxanthine, has exhibited broad effects on skin barrier function, leading to its launch as a cosmetic ingredient. A clinical trial on a lotion containing 0.1% 2-aza-8-oxohypoxanthine demonstrated the ability of this chemical to increase skin lightness based on the analysis of L* values. In the present study, to elucidate the mechanism underlying the increase in skin lightness, we aimed to investigate the effect of 2-aza-8-oxohypoxanthine on murine melanoma cell lines, focusing on its influence on tyrosinase activity and melanin production. Our findings revealed that the addition of 2-aza-8-oxohypoxanthine inhibited tyrosinase activity by 13% compared with the untreated control. Similarly, melanin production was suppressed by 36% compared with the control. These results strongly suggest that the inhibition of tyrosinase effectively suppressed melanin production. Thus, 2-aza-8-oxohypoxanthine acts by inhibiting tyrosinase and melanin production to promote skin lightening. This study provides novel insights into the skin-lightening mechanism of 2-aza-8-oxohypoxanthine, demonstrating its ability to inhibit melanin production through the suppression of pro-inflammatory factors, thereby highlighting its potential as an effective cosmetic ingredient for lightening skin tone.
No takes yet. Share an insight, caveat, or question.
Aoshima et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: